Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance

Abstract Along with the recent spread of multidrug-resistant bacteria, outbreaks of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing bacteria present a serious challenge to clinicians. β-lactam antibiotics are the most frequently used antibacterial agents and ESBLs, and carbapenemase...

Full description

Bibliographic Details
Main Authors: Teiji Sawa, Kunihiko Kooguchi, Kiyoshi Moriyama
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Journal of Intensive Care
Subjects:
Online Access:https://doi.org/10.1186/s40560-020-0429-6
_version_ 1818557195564875776
author Teiji Sawa
Kunihiko Kooguchi
Kiyoshi Moriyama
author_facet Teiji Sawa
Kunihiko Kooguchi
Kiyoshi Moriyama
author_sort Teiji Sawa
collection DOAJ
description Abstract Along with the recent spread of multidrug-resistant bacteria, outbreaks of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing bacteria present a serious challenge to clinicians. β-lactam antibiotics are the most frequently used antibacterial agents and ESBLs, and carbapenemases confer resistance not only to carbapenem antibiotics but also to penicillin and cephem antibiotics. The mechanism of β-lactam resistance involves an efflux pump, reduced permeability, altered transpeptidases, and inactivation by β-lactamases. Horizontal gene transfer is the most common mechanism associated with the spread of extended-spectrum β-lactam- and carbapenem resistance among pathogenic bacterial species. Along with the increase in antimicrobial resistance, many different types of ESBLs and carbapenemases have emerged with different enzymatic characteristics. For example, carbapenemases are represented across classes A to D of the Ambler classification system. Because bacteria harboring different types of ESBLs and carbapenemases require specific therapeutic strategies, it is essential for clinicians to understand the characteristics of infecting pathogens. In this review, we summarize the current knowledge on carbapenem resistance by ESBLs and carbapenemases, such as class A carbapenemases, class C extended-spectrum AmpC (ESAC), carbapenem-hydrolyzing class D β-lactamases (CHDLs), and class B metallo-β-lactamases, with the aim of aiding critical care clinicians in their therapeutic decision making.
first_indexed 2024-12-13T23:56:43Z
format Article
id doaj.art-eacdab616c644ca6be375a7cac4a0f77
institution Directory Open Access Journal
issn 2052-0492
language English
last_indexed 2024-12-13T23:56:43Z
publishDate 2020-01-01
publisher BMC
record_format Article
series Journal of Intensive Care
spelling doaj.art-eacdab616c644ca6be375a7cac4a0f772022-12-21T23:26:31ZengBMCJournal of Intensive Care2052-04922020-01-018111310.1186/s40560-020-0429-6Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistanceTeiji Sawa0Kunihiko Kooguchi1Kiyoshi Moriyama2Department of Anesthesiology, School of Medicine, Kyoto Prefectural University of MedicineDepartment of Intensive Care, Kyoto City HospitalDepartment of Anesthesiology, School of Medicine, Kyorin UniversityAbstract Along with the recent spread of multidrug-resistant bacteria, outbreaks of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing bacteria present a serious challenge to clinicians. β-lactam antibiotics are the most frequently used antibacterial agents and ESBLs, and carbapenemases confer resistance not only to carbapenem antibiotics but also to penicillin and cephem antibiotics. The mechanism of β-lactam resistance involves an efflux pump, reduced permeability, altered transpeptidases, and inactivation by β-lactamases. Horizontal gene transfer is the most common mechanism associated with the spread of extended-spectrum β-lactam- and carbapenem resistance among pathogenic bacterial species. Along with the increase in antimicrobial resistance, many different types of ESBLs and carbapenemases have emerged with different enzymatic characteristics. For example, carbapenemases are represented across classes A to D of the Ambler classification system. Because bacteria harboring different types of ESBLs and carbapenemases require specific therapeutic strategies, it is essential for clinicians to understand the characteristics of infecting pathogens. In this review, we summarize the current knowledge on carbapenem resistance by ESBLs and carbapenemases, such as class A carbapenemases, class C extended-spectrum AmpC (ESAC), carbapenem-hydrolyzing class D β-lactamases (CHDLs), and class B metallo-β-lactamases, with the aim of aiding critical care clinicians in their therapeutic decision making.https://doi.org/10.1186/s40560-020-0429-6β-Lactamβ-LactamaseCarbapenemaseClassificationMultidrug resistance
spellingShingle Teiji Sawa
Kunihiko Kooguchi
Kiyoshi Moriyama
Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
Journal of Intensive Care
β-Lactam
β-Lactamase
Carbapenemase
Classification
Multidrug resistance
title Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
title_full Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
title_fullStr Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
title_full_unstemmed Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
title_short Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
title_sort molecular diversity of extended spectrum β lactamases and carbapenemases and antimicrobial resistance
topic β-Lactam
β-Lactamase
Carbapenemase
Classification
Multidrug resistance
url https://doi.org/10.1186/s40560-020-0429-6
work_keys_str_mv AT teijisawa moleculardiversityofextendedspectrumblactamasesandcarbapenemasesandantimicrobialresistance
AT kunihikokooguchi moleculardiversityofextendedspectrumblactamasesandcarbapenemasesandantimicrobialresistance
AT kiyoshimoriyama moleculardiversityofextendedspectrumblactamasesandcarbapenemasesandantimicrobialresistance